ESSA Pharma
EPIX
EPIX was delisted on the 8th of October, 2025.
8 hedge funds and large institutions have $13.1M invested in ESSA Pharma in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
62% more capital invested
Capital invested by funds: $8.04M → $13.1M (+$5.02M)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.56% less ownership
Funds ownership: 66.24% → 60.68% (-5.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$223 |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$180 |
EPIX Hedge Fund Activity: Q1 2019 in Review
8 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q1 2019, worth a combined $13.1M — up 62% from $8.04M a quarter earlier.
Fund positioning in EPIX was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $223. The largest seller was Toronto Dominion Bank, cutting an estimated $180.
- 8 institutional investors held ESSA Pharma (EPIX) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $13.1M of ESSA Pharma stock for Q1 2019, up 62% quarter-over-quarter.
- 0 funds opened new ESSA Pharma positions in Q1 2019 and 0 closed out.
- The largest ESSA Pharma buyer in Q1 2019 was Royal Bank of Canada, an estimated $223 added.
- The largest ESSA Pharma seller in Q1 2019 was Toronto Dominion Bank, an estimated $180 sold.
Based on aggregated 13F filings for Q1 2019.